Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant.

Chemaitelly, Hiam; Bertollini, Roberto; Abu-Raddad, Laith J

Chemaitelly, Hiam; Bertollini, Roberto; Abu-Raddad, Laith J.

Chemaitelly H; Weill Cornell Medicine-Qatar, Doha, Qatar.
Bertollini R; Ministry of Public Health, Doha, Qatar.
Abu-Raddad LJ; Weill Cornell Medicine-Qatar, Doha, Qatar lja2002@qatar-med.cornell.edu.

N Engl J Med ; 385(27): 2585-2586, 2021 12 30.

Article in English | MEDLINE | ID: covidwho-1574004

Subject(s)

COVID-19/immunology; Immunity, Innate; Reinfection/immunology; SARS-CoV-2/immunology; Antibodies, Viral/blood; COVID-19/epidemiology; COVID-19/virology; Female; Humans; Incidence; Male; Qatar/epidemiology; Reinfection/epidemiology; Retrospective Studies

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Reinfection / SARS-CoV-2 / COVID-19 / Immunity, Innate Type of study: Observational study Topics: Variants Limits: Female / Humans / Male Country/Region as subject: Asia Language: English Journal: N Engl J Med Year: 2021 Document Type: Article Affiliation country: NEJMc2110300

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google